Answer :
Final answer:
Malignant neoplasm of the tail of the pancreas is reported with code C25.2. This code addresses malignant neoplasms in the digestive organs and is crucial for diagnosis and treatment planning. Pancreatic tumors and type I diabetes both impact blood sugar levels but in different ways.
Explanation:
Malignant neoplasm of the tail of the pancreas is reported with code C25.2. This code is part of the International Classification of Diseases, specifically within the section that deals with malignant neoplasms of digestive organs. The pancreas is an organ that can develop both exocrine and endocrine tumors, and given the location specified as the 'tail' in the question, these details are crucial for accurate coding and diagnosis.
Pancreatic neoplasms may cause excess secretion of glucagon, while Type I diabetes is characterized by a deficiency in insulin production. Pancreatic tumors and type I diabetes can both affect blood sugar levels, but in different ways. Answer (a) states that a pancreatic tumor and type I diabetes will have the opposite effects on blood sugar levels, which can be true since excess glucagon would raise blood sugar levels, whereas insulin deficiency would make it difficult to lower them.
However, detail is required regarding whether the tumor leads to over-production or under-production of insulin or other hormones, as not all pancreatic tumors cause hyperglycemia, and in some cases, they might lead to hypoglycemia depending on the hormone affected. Pancreatic cancer is often diagnosed late and has a low survival rate, largely because it is frequently discovered too late for curative surgery, which is currently the only definitive treatment option.
